Evidence map›Paper›PMID 29662465›Full record

ArticleFrontiers in neurology2018

The Length of

Lucia Corrado, Fabiola De Marchi, Sara Tunesi, Gaia Donata Oggioni, Miryam Carecchio, Luca Magistrelli, Silvana Tesei, Giulio Riboldazzi, Alessio Di Fonzo, Clarissa Locci and 11 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. The Impact ofLife (Basel, Switzerland) · 2021
    Review
  9. Review
  10. Review
  11. "Janus-Faced" α-Synuclein: Role in Parkinson's Disease.Frontiers in cell and developmental biology · 2021
    Review
  12. Review
  13. Article
  14. Aging · 2020
    Article
  15. Beta2-Adrenoceptor Agonists in Parkinson's Disease and Other Synucleinopathies.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 1 country.

Lucia CorradoLaboratory of Genetics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Fabiola De MarchiSection of Neurology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Sara TunesiUnit of Medical Statistics and Cancer Epidemiology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Gaia Donata OggioniSection of Neurology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Miryam CarecchioSection of Neurology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Luca MagistrelliSection of Neurology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Silvana TeseiParkinson Institute, ASST Gaetano Pini-CTO (Formerly ICP), Milan, Italy.
Giulio RiboldazziParkinson's Disease and Movement Disorders Center, Ospedale di Circolo Fondazione Macchi, University of Insubria, Varese, Italy.
Alessio Di FonzoNeuroscience Section, Department of Pathophysiology and Transplantation, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, University of Milan, Milan, Italy.
Clarissa LocciLaboratory of Genetics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Ilaria TrezziNeuroscience Section, Department of Pathophysiology and Transplantation, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, University of Milan, Milan, Italy.
Roberta ZangagliaParkinson's Disease and Movement Disorders Unit, C. Mondino National Institute of Neurology Foundation, IRCCS, Pavia, Italy.
Cristina CeredaGenomic and Post-Genomic Center, C. Mondino National Institute of Neurology Foundation, IRCCS, Pavia, Italy.
Sandra D'AlfonsoLaboratory of Genetics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
Corrado MagnaniUnit of Medical Statistics and Cancer Epidemiology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Giacomo P ComiNeuroscience Section, Department of Pathophysiology and Transplantation, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, University of Milan, Milan, Italy.
Giorgio BonoParkinson's Disease and Movement Disorders Center, Ospedale di Circolo Fondazione Macchi, University of Insubria, Varese, Italy.
Claudio PacchettiParkinson's Disease and Movement Disorders Unit, C. Mondino National Institute of Neurology Foundation, IRCCS, Pavia, Italy.
Roberto CantelloSection of Neurology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Stefano GoldwurmParkinson Institute, ASST Gaetano Pini-CTO (Formerly ICP), Milan, Italy.
Cristoforo ComiSection of Neurology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Milan · ITFondazione Istituto Neurologico Nazionale Casimiro Mondino · ITIstituto Ortopedico Gaetano Pini · ITOspedale di Circolo e Fondazione Macchi · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITItalian institute for Genomic Medicine · ITUniversity of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlpha-synuclein is a constituent of Lewy bodies and mutations of its gene cause familial Parkinson's disease (PD). A previous study showed that a variant of the alpha-synuclein gene (

methodsWe recruited and genotyped for

results

conclusion

Indexed as

dementiadisease progressiongenetic markershallucinationsParkinson’s disease

Identifiers

PMID29662465
PMCPMC5890103
OpenAlexW2795263640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.